Cite

HARVARD Citation

    Camm, A. et al. (2020). Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study. Clinical cardiology. 43 (12), pp. 1405-1413. [Online]. 
  
Back to record